CRISPR Therapeutics AG
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
- 3 insiders sold shares within a monthSince Oct 14, 2026+7.7
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
8 sales (5 not pre-planned) · 0 purchases
- Kulkarni SamarthChief Executive Officer · Oct 19, 2026Sold 47,837 sharesabout $2.4 million · not pre-planned
- George SimeonBoard member · Oct 14, 2026Sold 14,514 sharesabout $720 thousand · pre-planned
- KASINGER JAMES R.General Counsel and Secretary · Oct 14, 2026Sold 1,040 sharesabout $51 thousand · not pre-planned
- Kulkarni SamarthChief Executive Officer · Oct 14, 2026Sold 4,098 sharesabout $202 thousand · not pre-planned
- KASINGER JAMES R.General Counsel and Secretary · Oct 6, 2026Sold 1,990 sharesabout $119 thousand · pre-planned
- KASINGER JAMES R.General Counsel and Secretary · Sep 22, 2026Sold 10,400 sharesabout $626 thousand · pre-planned
- Behbahani AliBoard member · Sep 17, 2026Sold 13,679 sharesabout $781 thousand · not pre-planned
- Patel NaimishChief Medical Officer · May 29, 2026Sold 3,786 sharesabout $211 thousand · not pre-planned
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.